Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials: Clinical article

Journal of Neurosurgery

Volumn 118, Issue 1, 2013, Pages 3-12

  Ilodigwe, Don ^a,b   Murray, Gordon D ^e   Kassell, Neal F ^c   Torner, James ^d   Kerr, Richard S C ^f   Molyneux, Andrew J ^g   MacDonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Clinical trial; Statistical analysis; Subarachnoid hemorrhage; Vascular disorders; Vasospasm

Indexed keywords

CLAZOSENTAN; PLACEBO; TIRILAZAD;

AGE; ARTICLE; CLIP; FIXED DICHOTOMIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SLIDING DICHOTOMY; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PREGNATRIENES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS AS TOPIC; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84872200065     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.9.JNS111383     Document Type: Article

References (22)

1. Bath PM, Gray LJ, Collier T, Pocock S, Carpenter J: Can we improve the statistical analysis of stroke trials? Statistical reanalysis of functional outcomes in stroke trials. Stroke 38: 1911-1915, 2007
2. Bolland K, Sooriyarachchi MR, Whitehead J: Sample size review in a head injury trial with ordered categorical responses. Stat Med 17:2835-2847, 1998
3. Bonita R, Beaglehole R: Recovery of motor function after stroke. Stroke 19:1497-1500, 1988
4. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352:1245-1251, 1998
5. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995
6. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467-474, 1997
7. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1:480-484, 1975
8. Kassell NF, Haley ECJ Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996
9. Lanzino G, Kassell NF: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024, 1999
10. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, et al: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017, 1999
11. Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al: Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. Lancet 355:1949-1954, 2000
12. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al: Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015-3021, 2008
13. McHugh GS, Butcher I, Steyerberg EW, Marmarou A, Lu J, Lingsma HF, et al: A simulation study evaluating approaches to the analysis of ordinal outcome data in randomized controlled trials in traumatic brain injury: results from the IMPACT Project. Clin Trials 7:44-57, 2010
14. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365:387-397, 2005
15. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267-1274, 2002
16. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al: International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366:809-817, 2005
17. Murray GD, Barer D, Choi S, Fernandes H, Gregson B, Lees KR, et al: Design and analysis of phase III trials with ordered outcome scales: the concept of the sliding dichotomy. J Neurotrauma 22:511-517, 2005
18. Roozenbeek B, Lingsma HF, Perel P, Edwards P, Roberts I, Murray GD, et al: The added value of ordinal analysis in clinical trials: an example in traumatic brain injury. Crit Care 15: R127, 2011
19. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, et al: The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377:741-750, 2011
20. Saver JL: Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trials. Stroke 38:3055-3062, 2007
21. Senn S, Julious S: Measurement in clinical trials: a neglected issue for statisticians? Stat Med 28:3189-3209, 2009
22. Wilson JT, Pettigrew LE, Teasdale GM: Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15: 573-585, 1998